SCHEMBL24316797

SCHEMBL24316797

CCOc1cc(Oc2ccc3ncc(C)c(=O)n3c2)cnc1N

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.38
GLA P06280 3/20 0.38
GAA P10253 3/20 0.38
PIK3CA P42336 3/20 0.38
PRMT5 O14744 2/20 0.36
WDR77 Q9BQA1 2/20 0.36
NPBWR1 P48145 2/20 0.33
ALDH1A1 P00352 3/20 0.32
MTOR P42345 1/20 0.32
GRM5 P41594 2/20 0.32
MAPT P10636 1/20 0.32
DGAT2 Q96PD7 1/20 0.32
TLR8 Q9NR97 1/20 0.32
POLB P06746 1/20 0.31
HPGD P15428 2/20 0.31
MCHR1 Q99705 1/20 0.31
NPC1 O15118 1/20 0.31
TP53 P04637 1/20 0.31
CYP1A2 P05177 1/20 0.31
CYP2C19 P33261 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29539198 0.87 KDM4E (0.41) KDM4EGLAGAAPIK3CAPRMT5
SCHEMBL24316556 0.87 KDM4E (0.41) KDM4EGLAGAAPIK3CAPRMT5
SCHEMBL24316808 0.78 POLB (0.41) KDM4EGLAGAAPIK3CAPRMT5
SCHEMBL24316804 0.77 KDM4E (0.35) KDM4EGLAGAAPIK3CAALDH1A1
SCHEMBL24316426 0.77 CSF1R (0.46) KDM4EGLAGAADGAT2MCHR1
SCHEMBL24316434 0.74 CSF1R (0.53) KDM4EPIK3CANPBWR1ALDH1A1MTOR
SCHEMBL24316624 0.74 KDM4E (0.36) KDM4EGLAGAAPIK3CAALDH1A1
SCHEMBL29539473 0.74 KDM4E (0.36) KDM4EGLAGAAPIK3CAALDH1A1
SCHEMBL24316983 0.74 CSF1R (0.46) PIK3CAALDH1A1MTORGRM5TLR8
SCHEMBL24316982 0.74 CSF1R (0.48) KDM4EGLAGAAPIK3CANPBWR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240092774-A1 HETEROAROMATIC COMPOUNDS AND USES THEREOF HUTCHISON MEDIPHARMA LIMITED (CN) 2024-03-21 US disclosed
EP-4214198-A1 HETEROAROMATIC COMPOUNDS AND USES THEREOF Hutchison Medipharma Limited (CN) 2023-07-26 EP disclosed
WO-2022057895-A1 HETEROAROMATIC COMPOUNDS AND USES THEREOF HUTCHISON MEDIPHARMA LIMITED (CN) 2022-03-24 WO disclosed
WO-2022057895-A1 HETEROAROMATIC COMPOUNDS AND USES THEREOF HUTCHISON MEDIPHARMA LIMITED (CN) 2022-03-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240092774-A1 HETEROAROMATIC COMPOUNDS AND USES THEREOF CYP2D6, CYP3A7, CYP2F1 KDM4E 4085/4885GLA 1120/4885GAA 323/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.